๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Characterisation of the transcription factor, SIX5, using a new panel of monoclonal antibodies

โœ Scribed by Y Chan N. Pham; Nguyen thi Man; Ian Holt; Caroline A. Sewry; Gurman Pall; Keith Johnson; Glenn E. Morris


Book ID
102301256
Publisher
John Wiley and Sons
Year
2005
Tongue
English
Weight
333 KB
Volume
95
Category
Article
ISSN
0730-2312

No coin nor oath required. For personal study only.

โœฆ Synopsis


Abstract

SIX5 is a member of the human SIX family of transcription factors, many of which are involved in eye development. However, SIX5 transcripts are known to be present at very low levels in cells and no study has yet convincingly demonstrated detection of endogenous SIX5 protein by Western blotting or immunolocalisation. We have produced a new panel of 18 monoclonal antibodies (mAbs) that recognise at least four different epitopes in order to identify authentic human SIX5 protein in cells and tissues. Phageโ€displayed peptide libraries were used to identify individual aminoโ€acids important for antibody binding within each epitope. Endogenous SIX5 migrated in SDSโ€“PAGE with an apparent M~r~ of 100 kDa and was present at similar levels in all foetal tissues and cell lines tested. In HeLa cells, it was located in the nucleoplasm with a granular distribution. An mRNA for a shorter splicing isoform of SIX5, with an altered carboxyโ€terminus, has been described, but further mAbs specific for this isoform did not detect any endogenous protein. We conclude that the fullโ€length isoform is the major functional protein in vivo while the putative shorter protein is undetectable and may not be expressed at all. ยฉ 2005 Wileyโ€Liss, Inc.


๐Ÿ“œ SIMILAR VOLUMES


A study of the antigenicity and immunoge
โœ Waters, J. A.; Bailey, C.; Love, C.; Thomas, H. C. ๐Ÿ“‚ Article ๐Ÿ“… 1998 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 150 KB ๐Ÿ‘ 2 views

The successful prevention of infection with hepatitis B virus (HBV) has been achieved by vaccination with purified hepatitis B surface antigen (HBsAg). The ability of a novel synthetic HBV envelope antigen vaccine (Hep B-3, Hepa-geneโ„ข; Medeva), which contains part of the pre-S1 and the complete pre-